Hecker L I, McClusky G A
Cancer Res. 1982 Jan;42(1):59-64.
The in vitro metabolism of N-nitrosohexamethyleneimine by lung and liver microsomes and cytosol from uninduced male Fischer rats is described. Metabolites produced by both organs appeared to be identical. The liver subcellular fractions had a lower Km (0.6 mM) than did lung fractions (3 mM) and metabolized 2.5 to 5 times as much nitrosamine per mg protein. Our results, together with those from our earlier studies, indicate that, as the size of the carbon ring increases from nitrosopyrolidine to nitrosohexamethyleneimine, lung microsomes had an increased affinity for the cyclic nitrosamines; they was only a small effect with liver enzymes. Ths suggests that microsomal enzymes that metabolize cyclic nitrosamines in rat livers and lungs are not the same. The first stable alpha-hydroxylation product, 6-hydroxyhexanal, was not detected in reactions involving microsomes alone. Apparently, this compound is rapidly converted to 1,6-hexanediol by liver or lung microsomes. The presence of cytosol was needed for the full conversion of these metabolites to xi-hydroxycaproate and maximal alpha-hydroxylation activity. xi-Aminocaproate was always found in direct proportion to the hydroxyacid, suggesting that both acids arise from the same alpha-hydroxylation event by different breakdown mechanisms. beta- and gamma-hydroxynitrosohexamethyleneimine were not metabolized significantly by rat liver enzymes and thus, in this species, may be "detoxification products" of N-nitrosohexamethyleneimine.
描述了未诱导的雄性Fischer大鼠的肺和肝微粒体及胞质溶胶对N-亚硝基六亚甲基亚胺的体外代谢情况。两个器官产生的代谢物似乎相同。肝亚细胞组分的Km(0.6 mM)低于肺组分(3 mM),每毫克蛋白质代谢的亚硝胺量是肺组分的2.5至5倍。我们的结果与早期研究结果共同表明,随着碳环大小从亚硝基吡咯烷增加到亚硝基六亚甲基亚胺,肺微粒体对环状亚硝胺的亲和力增加;而对肝酶的影响较小。这表明大鼠肝脏和肺中代谢环状亚硝胺的微粒体酶不同。在仅涉及微粒体的反应中未检测到第一种稳定的α-羟基化产物6-羟基己醛。显然,该化合物会被肝或肺微粒体迅速转化为1,6-己二醇。将这些代谢物完全转化为ξ-羟基己酸酯并达到最大α-羟基化活性需要胞质溶胶的存在。总是发现ξ-氨基己酸与羟基酸成正比,这表明两种酸是由相同的α-羟基化事件通过不同的分解机制产生的。β-和γ-羟基亚硝基六亚甲基亚胺未被大鼠肝酶显著代谢,因此,在该物种中,它们可能是N-亚硝基六亚甲基亚胺的“解毒产物”。